GT
NVTR

Glenmede Trust’s Nuvectra Corporation Common Stock NVTR Stock Holding History

Glenmede Trust’s Portfolio NVTR Stock Details NVTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-32
Closed – – 2781
2016
Q1 		$0 Buy
+32
New +$172 ﹤0.01% 2773

Other funds holding NVTR

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Glenmede Trust's NVTR Position: Q2 2016 in Review

Glenmede Trust sold out of Nuvectra Corporation Common Stock (NVTR) in Q2 2016, closing a stake of 32 shares.

Glenmede Trust first reported a position in NVTR in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 87 funds tracked by Wall St. Rank hold NVTR as of Q2 2016.

  • Glenmede Trust reported no remaining Nuvectra Corporation Common Stock position as of Q2 2016 after selling out during the quarter.
  • Glenmede Trust sold 32 Nuvectra Corporation Common Stock shares in Q2 2016.
  • Glenmede Trust first reported a position in Nuvectra Corporation Common Stock in Q1 2016 and held it in 1 quarter.
  • Glenmede Trust's Nuvectra Corporation Common Stock position peaked at $0 in Q1 2016.
  • 87 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q2 2016.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.